6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
6m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
6m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
6m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
7m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

2.79USD-0.03 -1.10%

Closed • Updated at 13:54 GMT+00:00

Market Cap$542.39M

Volume98.1K

Beta0.43

RSI39.95

Gross Margin-194.44%

Health TechnologyBiotechnology

Altimmune, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Altimmune Announces First Quarter 2026 Financial Results and Business Update

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026

Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

Community Chat

Ask AI